Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Curr Opin Biotechnol ; 24(2): 160-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22940212

ABSTRACT

Food-related lactic acid bacteria (LAB) as well as human gut commensals such as bifidobacteria can de novo synthesize and supply vitamins. This is important since humans lack the biosynthetic capacity for most vitamins and these must thus be provided exogenously. Although vitamins are present in a variety of foods, deficiencies still occur, mainly due to malnutrition as a result of insufficient food intake and because of poor eating habits. Fermented milks with high levels of B-group vitamins (such as folate and riboflavin) can be produced by LAB-promoted and possibly bifidobacteria-promoted biosynthesis. Moreover, certain strains of LAB produce the complex vitamin cobalamin (or vitamin B12). In this review, fermented foods with elevated levels of B-group vitamins produced by LAB used as starter cultures will be covered. In addition, genetic abilities for vitamin biosynthesis by selected human gut commensals will be discussed.


Subject(s)
Bacteria/metabolism , Intestines/microbiology , Metagenome/physiology , Vitamins/metabolism , Folic Acid/metabolism , Humans , Lactic Acid/metabolism , Riboflavin/metabolism , Vitamin B 12/biosynthesis , Vitamin B 12/metabolism , Vitamin K/biosynthesis , Vitamin K/metabolism , Vitamins/biosynthesis
2.
J Headache Pain ; 6(5): 417-9, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16362716

ABSTRACT

Chronic cluster headache remains refractory to medical therapy in at least 30% of those who suffer from this condition. The lack of alternative medical therapies that are as effective as, or more effective than, lithium carbonate makes new therapies necessary for this highly disabling condition. Based on a previous report, we gave oral anticoagulants to three patients with chronic cluster headache. Two of them remained cluster headache-free while taking warfarin. In the third patient, the use of warfarin for three weeks initially increased the frequency and intensity of cluster headache attacks but subsequently induced a prolonged remission. In spite of the paucity of data available, oral anticoagulation appears to be a promising therapy for chronic cluster headache.


Subject(s)
Anticoagulants/administration & dosage , Cluster Headache/drug therapy , Warfarin/administration & dosage , Administration, Oral , Anticoagulants/adverse effects , Brain/drug effects , Brain/metabolism , Brain/physiopathology , Cluster Headache/physiopathology , Disease Progression , Encephalitis/drug therapy , Encephalitis/metabolism , Encephalitis/prevention & control , Humans , Hypothalamus/drug effects , Hypothalamus/metabolism , Hypothalamus/physiopathology , Male , Middle Aged , Remission Induction/methods , Treatment Outcome , Trigeminal Nuclei/drug effects , Trigeminal Nuclei/metabolism , Trigeminal Nuclei/physiopathology , Vitamin K/biosynthesis , Warfarin/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL